Periodontal Defect Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Periodontal Defect clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts

Periodontal DiseasesPeriodontitisIntrabony Periodontal Defect+2 more
Saglik Bilimleri Universitesi16 enrolled1 locationNCT07146776
Recruiting
Not Applicable

Effect of Collagen Membranes on Distal Periodontal Healing of Second Molars After Impacted Mandibular Third Molar Surgery.

Periodontal Defect
University of Medicine and Pharmacy at Ho Chi Minh City20 enrolled1 locationNCT07114523
Recruiting
Phase 4

Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects

Intrabony Periodontal Defect
Cairo University24 enrolled1 locationNCT06048042
Recruiting
Phase 1Phase 2

Rh-PDGF vs EMD for Treatment of Intra-bony Defects

Intrabony Periodontal Defect
Nova Southeastern University36 enrolled1 locationNCT05442034
Recruiting
Not Applicable

Clinical and Radiographic Evaluation of Using the Entire Papilla Preservation Technique With and Without Autogenous Bone Graft and Injectable Platelet Rich Fibrin in Treatment of Periodontal Intraosseous Defects

Isolated Intrabony Periodontal Defects in Patients With Periodontitis
Cairo University24 enrolled1 locationNCT06347263
Recruiting
Not Applicable

Efficacy of Insulin Like Growth Factor-1(IGF-1) on Bone Regeneration in Intrabony Defects : A Clinico-radiograph Study

Intrabony Periodontal Defect
Dr R Viswa Chandra24 enrolled1 locationNCT06426524
Recruiting

chronOS Implant Evaluation Study. The Canberra Surgicentre and Synthes Australia are conducting a clinical study to evaluate the performance of chronOS granules (bone substitute) following the extraction of wisdom tooth/teeth to prevent the risk of periodontal defects.

Dental health.Mandibular M3 extraction may result in bony periodontal defects on the distal surface of the adjacent second molar.
Canberra Surgicentre100 enrolled1 locationACTRN12608000092392